Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-062258
Filing Date
2025-05-02
Accepted
2025-05-02 07:14:02
Documents
91
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-20250331.htm   iXBRL 10-Q 2796411
2 EX-10.1 flgt-ex10_1.htm EX-10.1 43249
3 EX-31.1 flgt-ex31_1.htm EX-31.1 16274
4 EX-31.2 flgt-ex31_2.htm EX-31.2 16419
5 EX-32.1 flgt-ex32_1.htm EX-32.1 18874
  Complete submission text file 0000950170-25-062258.txt   13169464

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20250331.xsd EX-101.SCH 1491272
93 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20250331_htm.xml XML 3027887
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 25905481
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)